Last reviewed · How we verify

NCT05024916

Blueberry Intervention Study for Brain Aging

Completed NA Last updated 21 May 2025
What this trial tests

NA trial testing Intervention in Brain Aging in 63 participants. Completed in 3 October 2024.

Timeline
1 June 2022
Primary endpoint
3 October 2024
3 October 2024

Quick facts

Lead sponsorUniversity of Kansas Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment63
Start date1 June 2022
Primary completion3 October 2024
Estimated completion3 October 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Kansas Medical Center

Who can join

Adults 65 to 89, any sex, with Brain Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine if increased blueberry intake helps increase brain antioxidant (glutathione) and cerebral blood flow in older adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Intervention

Trials testing the same drug.

Other recruiting trials for Brain Aging

Currently open trials in the same condition.

Other University of Kansas Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05024916.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing